Bob Cunard

Bob Cunard is an accomplished executive with extensive experience in the pharmaceutical and healthcare industries. Currently serving as Operating Partner at HealthEdge Investment Partners since June 2017, Cunard also previously held the position of CEO at The Columbus Organization from January 2017 to November 2021. Prior roles include CEO of Aurobindo Pharma USA, Inc., and Vice President of Sales at Teva Pharmaceuticals. Cunard has also held significant leadership positions at Glades Pharmaceuticals, Stiefel Laboratories, and Mylan Pharmaceuticals, among others. Educationally, Cunard holds a Bachelor of Arts in Business Economics from the University of Pittsburgh.